Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Orphenadrine recalled?

Not under an active recall. Orphenadrine was recalled 5 times in the past — all now closed. Most recent: Mar 21, 2022.

Most common reason: Cross-contamination (1 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Orphenadrine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Orphenadrine recalls on record

none so far in 2026; 5 on record, newest first
Class II · Moderate risk

Orphenadrine Citrate active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-826-2015
Class II · Moderate risk

ORPHENADRINE CITRATE ER Tablet

Labeling: Label Mixup; ORPHENADRINE CITRATE ER Tablet, 100 mg may be potentially mislabeled as OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: W002965, EXP: 6/10/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-566-2014